BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
9.15
-0.16 (-1.67%)
Mar 31, 2025, 10:45 AM EDT - Market open
BrainsWay Revenue
In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth. BrainsWay had revenue of $11.41M in the quarter ending December 31, 2024, with 26.41% growth.
Revenue (ttm)
$41.02M
Revenue Growth
+29.04%
P/S Ratio
4.24
Revenue / Employee
$306,090
Employees
134
Market Cap
173.74M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BWAY News
- 20 days ago - BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 3 months ago - BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder - GlobeNewsWire
- 4 months ago - BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy - GlobeNewsWire
- 4 months ago - BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 5 months ago - BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 - GlobeNewsWire
- 6 months ago - BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea - GlobeNewsWire